Showing results (141-150 of 248) with videos related to
Sort By:
Pageof 25
Hematological Oncology|August 2, 2020
Targeted next-generation sequencing reveals molecular heterogeneity in non-chronic lymphocytic leukemia clonal B-cell lymphocytosisIrene Defrancesco, Silvia Zibellini, Emanuela Boveri, et al.Hematological Oncology|May 25, 2022
Obinutuzumab does not improve complete methabolic response but does not compromise mobilization or engraftment of autologous peripheral blood stem cells in diffuse large B cell lymphoma: Results from a fondazione italiana linfomi prospective phase II study (the GIOTTO study)Luigi Rigacci, Roberta Battistini, Sofia Kovalchuk, et al.Cancers|June 22, 2023
Clinical and Histopathological Features of an Italian Monocentric Series of Primary Small Bowel T-Cell LymphomasMarco Lucioni, Sara Fraticelli, Giovanni Santacroce, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 13, 2026
Clinical features and survival in primary intestinal lymphomas: A multicentre studyNicola Aronico, Giovanni Santacroce, Marco Lucioni, et al.Blood|October 2, 2019
Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter studyCarlo Visco, Francesco Rodeghiero, Alessandra Romano, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2009
Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor projectMassimo Federico, Monica Bellei, Luigi Marcheselli, et al.British Journal of Haematology|August 29, 2012
Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: development and validation on 593 casesCarlos Montalbán, Víctor Abraira, Luca Arcaini, et al.Cancer Reports (Hoboken, N.J.)|July 19, 2022
Durvalumab as monotherapy and in combination therapy in patients with lymphoma or chronic lymphocytic leukemia: The FUSION NHL 001 trialCarla Casulo, Armando Santoro, Guillaume Cartron, et al.American Journal of Hematology|December 16, 2014
Autologous stem cell transplantation with in vivo purged progenitor cells shows long-term efficacy in relapsed/refractory follicular lymphomaLuca Arcaini, Lucia Morello, Alessandra Tucci, et al.JCO Clinical Cancer Informatics|October 22, 2019
Applying Data Warehousing to a Phase III Clinical Trial From the Fondazione Italiana Linfomi Ensures Superior Data Quality and Improved Assessment of Clinical OutcomesGian Maria Zaccaria, Simone Ferrero, Samanta Rosati, et al.Pageof 25